The Saskatchewan government has agreed to a $40 million deal with Ottawa to improve access to medication for rare ...

Denileukin diftitox is under clinical development by Citius Oncology and currently in Pre-Registration for Mycosis Fungoides.

The most common type of CTCL is mycosis fungoides (MF). Mycosis fungoides was so named by a French dermatologist in the 1800s due to the mushroom like tumors that developed on the skin of a ...

ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase I drugs for Mycosis Fungoides have an 85% phase transition ...

A bilateral agreement will help improve access to drugs to treat rare diseases for Saskatchewan residents, the provincial and ...

By far the most common variant of CTCL is mycosis fungoides and its leukemic variant Sézary syndrome. Mycosis fungoides imposes a tremendous physical as well as psychological burden for patients ...

Considering taking supplements to treat mycosis fungoides? Below is a list of common natural remedies used to treat or reduce the symptoms of mycosis fungoides. Follow the links to read common ...

Fungal infections, aka mycosis, are conditions caused by fungi. These infections are pretty common, and while many are not deemed to be serious health threats, others can be a cause for concern.

Mycosis fungoides is a type of skin cancer that affects the body's T cells, which are white blood cells intended to protect the body from infection. It is the most common form of cutaneous T-cell ...

Marshall Davies was diagnosed with Folliculotropic mycosis fungoides, a rare and potentially aggressive type of cutaneous T-cell lymphoma, last year. Last week, non-profit organisation Race ...

The TELLOMAK study addresses an unmet need for patients with advanced-stage CTCL, particularly Sezary syndrome and mycosis fungoides, who often experience debilitating symptoms such as severe ...